Elbassioni, A. A. M. et al. (2025) Targeting Runx1 protects against heart failure with preserved ejection fraction. bioRxiv, (doi: 10.1101/2025.01.24.634831)

McIntosh, B., Elbassioni, A., Raheem, A., MacDonald, E. A. , Nicklin, S. A. , Koay, Y. C., Cameron, E. R. , Loughrey, C. M. and O'Sullivan, J. F. (2025) Optimized protocols for commonly-used murine models of heart failure with preserved ejection fraction. bioRxiv, (doi: 10.1101/2025.01.22.634221)

Loughrey, C. et al. (2024) A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic action: Pre-clinical and phase I study. British Journal of Pharmacology, 181(18), pp. 3401-3419. (doi: 10.1111/bph.16379) (PMID:38773354)

He, W. et al. (2022) Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size. Cardiovascular Research, 118(6), pp. 1535-1547. (doi: 10.1093/cvr/cvab204) (PMID:34132807)

Martin, T. P. , MacDonald, E. A. , Elbassioni, A. A., Zaeri, A. A. I., O'Toole, D., Nicklin, S. A. , Gray, G. A. and Loughrey, C. M. (2022) Pre-clinical models of myocardial infarction: from mechanism to translation. British Journal of Pharmacology, 179(5), pp. 770-791. (doi: 10.1111/bph.15595) (PMID:34131903)

MacDonald, E. A. and Quinn, T. A. (2021) What keeps us ticking? Sinoatrial node mechano-sensitivity: the grandfather clock of cardiac rhythm. Biophysical Reviews, 13(5), pp. 707-716. (doi: 10.1007/s12551-021-00831-8) (PMID:34777615)